Compensation award — excluded from discretionary-purchase analysis.
Loading…
Reporting person on SEC Form 4
Robert Eckert
Robert Eckert is Director at Amgen. OQRO lists 2 transactions filed with the SEC under this name, the latest on May 21, 2026, each linked to the official Form 4.
Director
Disclosures on record
2
Companies involved
2
Disclosure history
Compensation award — excluded from discretionary-purchase analysis.